Advertisement
Screener

TETRAPHASE PHARMACEUTICALS INC Net Cash Provided by (Used in) Financing Activities, Continuing Operations

TETRAPHASE PHARMACEUTICALS INC Net Cash Provided by (Used in) Financing Activities, Continuing Operations

TETRAPHASE PHARMACEUTICALS INC reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $231.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2018-05-03

  • TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for the quarter ending 2018-03-31 was $231.00K, a 95.66% decline year-over-year.
  • TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-12-31 was $1.92M, a 1421.43% increase year-over-year.
  • TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-09-30 was $69.23M, a 75979.12% increase year-over-year.
  • TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-06-30 was $16.68M, a 16409.90% increase year-over-year.
  • TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for fiscal 2017 was $93.15M, a 27871.77% increase from fiscal 2016.
  • TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $333.00K, a 99.79% decline from fiscal 2015.
  • TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $162.41M, a 113.30% increase from fiscal 2014.
  • TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $76.14M, a 35.62% decline from fiscal 2013.
Period endNet Cash Provided by (Used in) Financing Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 12 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 93 month
2018-03-31$231.00K
10-Q · filed 2018-05-03
$2.15M
derived: sum of 2 quarters · filed 2018-05-03
$71.38M
derived: sum of 3 quarters · filed 2018-05-03
$88.06M
derived: sum of 4 quarters · filed 2018-05-03
2017-12-31$1.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06
$71.15M
derived: sum of 2 quarters · filed 2018-03-06
$87.82M
derived: sum of 3 quarters · filed 2018-03-06
$93.15M
10-K · filed 2018-03-06
2017-09-30$69.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
$85.91M
derived: sum of 2 quarters · filed 2017-11-01
$91.23M
10-Q · filed 2017-11-01
$91.36M
derived: sum of 4 quarters · filed 2018-05-03
2017-06-30$16.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$22.00M
10-Q · filed 2017-08-02
$22.12M
derived: sum of 3 quarters · filed 2018-05-03
$22.21M
derived: sum of 4 quarters · filed 2018-05-03
2017-03-31$5.32M
10-Q · filed 2018-05-03
$5.45M
derived: sum of 2 quarters · filed 2018-05-03
$5.54M
derived: sum of 3 quarters · filed 2018-05-03
$5.64M
derived: sum of 4 quarters · filed 2018-05-03
2016-12-31$126.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06
$217.00K
derived: sum of 2 quarters · filed 2018-03-06
$318.00K
derived: sum of 3 quarters · filed 2018-03-06
$333.00K
10-K · filed 2018-03-06
2016-09-30$91.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
$192.00K
derived: sum of 2 quarters · filed 2017-11-01
$207.00K
10-Q · filed 2017-11-01
$378.00K
derived: sum of 4 quarters · filed 2018-03-06
2016-06-30$101.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$116.00K
10-Q · filed 2017-08-02
$287.00K
derived: sum of 3 quarters · filed 2018-03-06
$1.50M
derived: sum of 4 quarters · filed 2018-03-06
2016-03-31$15.00K
10-Q · filed 2017-05-08
$186.00K
derived: sum of 2 quarters · filed 2018-03-06
$1.40M
derived: sum of 3 quarters · filed 2018-03-06
$3.38M
derived: sum of 4 quarters · filed 2018-03-06
2015-12-31$171.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06
$1.39M
derived: sum of 2 quarters · filed 2018-03-06
$3.37M
derived: sum of 3 quarters · filed 2018-03-06
$162.41M
10-K · filed 2018-03-06
2015-09-30$1.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$3.20M
derived: sum of 2 quarters · filed 2016-11-03
$162.24M
10-Q · filed 2016-11-03
$242.66M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30$1.98M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$161.03M
10-Q · filed 2016-08-04
$241.45M
derived: sum of 3 quarters · filed 2017-03-13
$239.93M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$159.04M
10-Q · filed 2016-05-04
$239.46M
derived: sum of 2 quarters · filed 2017-03-13
$237.95M
derived: sum of 3 quarters · filed 2017-03-13
$236.49M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31$80.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$78.90M
derived: sum of 2 quarters · filed 2017-03-13
$77.45M
derived: sum of 3 quarters · filed 2017-03-13
$76.14M
10-K · filed 2017-03-13
2014-09-30-$1.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
-$2.97M
derived: sum of 2 quarters · filed 2015-11-02
-$4.27M
10-Q · filed 2015-11-02
$39.90M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30-$1.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$2.76M
10-Q · filed 2015-08-06
$41.41M
derived: sum of 3 quarters · filed 2016-02-25
$40.10M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31-$1.30M
10-Q · filed 2015-05-07
$42.86M
derived: sum of 2 quarters · filed 2016-02-25
$41.56M
derived: sum of 3 quarters · filed 2016-02-25
$45.96M
derived: sum of 4 quarters · filed 2016-02-25
$208.09M
10-Q · filed 2014-05-12
2013-12-31$44.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$42.86M
derived: sum of 2 quarters · filed 2016-02-25
$47.27M
derived: sum of 3 quarters · filed 2016-02-25
$118.27M
10-K · filed 2016-02-25
2013-09-30-$1.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$3.10M
derived: sum of 2 quarters · filed 2014-11-10
$74.10M
10-Q · filed 2014-11-10
2013-06-30$4.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$75.41M
10-Q · filed 2014-08-12
2013-03-31$71.00M
10-Q · filed 2014-05-12
2012-12-31$3.34M
10-K · filed 2015-03-06